Drug
Nabilone clinical trials
Also written Cesamet.
- studies test it
- 29
- open now
- 2
- in phase 3
- 9
- first study started
- 2005
Keep track of what changes. Save the nabilone studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
29 studies that test it; most in 2006 (6)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2006 | 6 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2012 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 4 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 15
- Phase 3
- 9
- Phase 4
- 6
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 26
University of Manitoba (4) · NEMA Research, Inc. (3) · Centre for Addiction and Mental Health (2) · Medical University Innsbruck (2) · Sunnybrook Health Sciences Centre (2) · New York State Psychiatric Institute (2) · Hsiang-Yuan Lin (1) · Eldon Loh, MD (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses nabilone is read from its arms, and is right about nine times in ten.
Testing it · 29
- Nabilone for Agitation Blinded Intervention TrialRecruitingPhase 3Sunnybrook Health Sciences CentreNCT04516057Written as Nabilone
- Nabilone Use For Acute Pain in Inflammatory Bowel Disease PatientsNot yet recruitingNot applicableSamuel Lunenfeld Research Institute, Mount Sinai HospitalNCT03422861Written as Nabilone
- Nabilone for Agitation in Frontotemporal DementiaTerminatedPhase 2Simon Ducharme, MDNCT05742698Written as Nabilone
- A Pilot Trial of Nabilone for the Treatment of ObesityTerminatedPhase 2Centre for Addiction and Mental HealthNCT04801641Written as Nabilone
- Investigating the Effects of Nabilone on Endocannabinoid MetabolismCompletedPhase 4Centre for Addiction and Mental HealthNCT05885685Written as Nabilone Oral Capsule
- Clinical Trial of Nabilone for Aggression in Adults With Intellectual and Developmental DisabilitiesCompletedPhase 1Hsiang-Yuan LinNCT05273320Written as Nabilone
- Cannabinoids and an Anti-inflammatory Diet for the Treatment of Neuropathic Pain After Spinal Cord InjuryCompletedPhase 3Eldon Loh, MDNCT04057456Written as Nabilone Capsules
- Multimodal Assessment of Cannabinoid Target Engagement in Adults With Obsessive-Compulsive DisorderWithdrawnPhase 1/2New York State Psychiatric InstituteNCT04880278Written as Nabilone
- DIalysis Symptom COntrol-Pruritus Outcome TrialCompletedPhase 3University of ManitobaNCT05180968Written as Nabilone 0.5 MG Oral Capsule
- Nabilone in Cannabis Users With PTSDTerminatedPhase 1/2New York State Psychiatric InstituteNCT03251326Written as Nabilone
- Adjunctive CB1 Agonist Nabilone in Inpatients With Active Suicidal IdeationWithdrawnPhase 2The University of Texas Health Science Center, HoustonNCT04807829Written as Nabilone
- Nabilone for Non-motor Symptoms in Parkinson's DiseaseCompletedPhase 2Medical University InnsbruckNCT03769896Written as Nabilone 0.25 mg
- Nabilone for Non-motor Symptoms in Parkinson's DiseaseCompletedPhase 3Medical University InnsbruckNCT03773796Written as Nabilone 0.25 mg
- Safety and Efficacy of Nabilone in Alzheimer's DiseaseCompletedPhase 2/3Sunnybrook Health Sciences CentreNCT02351882Written as Nabilone
- Nabilone for Cannabis Dependence: A Pilot StudyCompletedPhase 2/3Mclean HospitalNCT01347762Written as Nabilone
- Nabilone Effect on the Attenuation of Anorexia, Nutritional Status and Quality of Life in Lung Cancer PatientsStatus unknownPhase 2/3Instituto Nacional de Cancerologia de MexicoNCT02802540Written as Nabilone
- Study of Prevention of Postoperative Nausea and Vomiting Using CesametCompletedPhase 2Unity Health TorontoNCT02115529Written as Nabilone
- Effect of Cannabinoids on Spasticity and Neuropathic Pain in Spinal Cord Injured PersonsCompletedPhase 2University of ManitobaNCT01222468Written as nabilone 0.5 mg
- Efficacy and Safety Evaluation of Nabilone as Adjunctive Therapy to Gabapentin for the Management of Neuropathic Pain in Multiple SclerosisCompletedPhase 4University of ManitobaNCT00480181Written as nabilone
- A Trial Assessing the Effect of Nabilone on Pain and Quality of Life in Patients With FibromyalgiaCompletedPhase 2Winnipeg Regional Health AuthorityNCT00272207Written as Nabilone
See all 29 studies that test nabilone →
Given in every arm · 1 — nabilone is usual care beside what is tested
As the comparator · 2 — what is tested is compared with nabilone
Codes
What other systems call nabilone · ClinicalTrials.gg INT002539
- MeSH (NLM) C011941nabiloneConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 2N4O9L084NNABILONEConfirmed FDA, NLM, Wikidata
- RxNorm 31447Confirmed FDA, Wikidata
- Wikidata Q419079nabiloneConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1171NabiloneOne source FDA
- DrugBank DB00486One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C011941 | nabilone | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 2N4O9L084N | NABILONE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 31447 | — | Confirmed FDA, Wikidata |
| Wikidata | Q419079 | nabilone | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1171 | Nabilone | One source FDA |
| DrugBank | DB00486 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.